BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 102 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,150,558 | +6.7% | 727,480 | +6.1% | 0.03% | +14.3% |
Q2 2023 | $4,825,983 | -16.4% | 685,509 | -0.9% | 0.03% | -22.2% |
Q1 2023 | $5,770,304 | -27.7% | 691,883 | -0.5% | 0.04% | -30.8% |
Q4 2022 | $7,985,499 | +26.1% | 695,601 | +38.4% | 0.05% | +18.2% |
Q3 2022 | $6,333,000 | +55.2% | 502,581 | +30.3% | 0.04% | +63.0% |
Q2 2022 | $4,081,000 | -36.0% | 385,702 | -1.6% | 0.03% | -22.9% |
Q1 2022 | $6,374,000 | +40.5% | 392,008 | +19.7% | 0.04% | +45.8% |
Q4 2021 | $4,536,000 | +41.3% | 327,532 | +46.6% | 0.02% | +41.2% |
Q3 2021 | $3,210,000 | +6878.3% | 223,406 | +7577.2% | 0.02% | – |
Q2 2021 | $46,000 | +820.0% | 2,910 | +500.0% | 0.00% | – |
Q1 2021 | $5,000 | +150.0% | 485 | +44.8% | 0.00% | – |
Q4 2020 | $2,000 | -99.1% | 335 | -98.8% | 0.00% | -100.0% |
Q1 2017 | $228,000 | +14.6% | 27,165 | -13.7% | 0.00% | 0.0% |
Q4 2016 | $199,000 | +43.2% | 31,477 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $139,000 | +80.5% | 31,477 | +15.9% | 0.00% | – |
Q2 2016 | $77,000 | -11.5% | 27,165 | +223.7% | 0.00% | – |
Q4 2015 | $87,000 | +89.1% | 8,393 | +110.1% | 0.00% | – |
Q3 2015 | $46,000 | -45.9% | 3,995 | -30.0% | 0.00% | – |
Q2 2015 | $85,000 | -96.7% | 5,708 | -97.7% | 0.00% | -100.0% |
Q1 2014 | $2,605,000 | – | 246,190 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |